5-SENSE评分的开发与验证:预测立体定向脑电图评估的癫痫发作起始区局灶性
该研究开发并验证了5-SENSE评分,用于预测立体定向脑电图(SEEG)能否定位局灶性发作起始区。开发队列128例,验证队列207例,评分包含5个预测变量。开发队列曲线下面积0.83,特异度76.3%,敏感度83.3%;验证队列特异度76.0%,敏感度52.3%。
要点
- 5-SENSE评分由5个预测变量组成,用于预测SEEG能否定位局灶性发作起始区。
- 开发队列特异度76.3%(95% CI,66.7-85.8),敏感度83.3%(95% CI,72.30-94.1)。
- 验证队列特异度76.0%(95% CI,67.5-84.0),敏感度52.3%(95% CI,43.0-61.5)。
核心结论
- 开发和验证中的高特异度证实5-SENSE评分可预测SEEG不太可能识别局灶性发作起始区的患者。
- 该评分是简单有用的工具,可帮助临床医生减少患者不必要的侵入性诊断负担和有限医疗资源的过度使用。
研究设计与样本
- 单中心队列研究用于评分开发,随后进行多中心验证,患者选择间隔分别为2002年2月至2018年10月和2002年5月至2019年12月。
- 最低随访期为1年。
- 评分开发分析了在蒙特利尔神经学研究所接受SEEG的药物难治性癫痫患者,选择标准为脑电图中2次或以上癫痫发作且具有完整神经心理学和神经影像学数据集。
- 验证纳入来自9个癫痫中心的符合这些标准的患者。
- 分析于2021年5月至7月进行。
主要发现
- 评分包含以下5个预测变量:结构性磁共振成像上的局灶性病变、头皮脑电图中无双侧独立棘波、定侧神经心理学缺陷、强烈定侧的发作症状学、以及区域性的发作期头皮脑电图起始。
- 5-SENSE评分识别局灶性发作起始区的最佳平均(SD)概率截断值为37.6(3.5)。
- 开发队列曲线下面积为0.83,特异度76.3%(95% CI,66.7-85.8),敏感度83.3%(95% CI,72.30-94.1)。
- 验证队列特异度76.0%(95% CI,67.5-84.0),敏感度52.3%(95% CI,43.0-61.5)。
关键数值与推荐
- 5-SENSE评分包含5个预测变量:结构性磁共振成像上的局灶性病变、头皮脑电图中无双侧独立棘波、定侧神经心理学缺陷、强烈定侧的发作症状学、区域性的发作期头皮脑电图起始。
- 最佳平均(SD)概率截断值为37.6(3.5)。
- 开发队列曲线下面积0.83,特异度76.3%(95% CI,66.7-85.8),敏感度83.3%(95% CI,72.30-94.1)。
- 验证队列特异度76.0%(95% CI,67.5-84.0),敏感度52.3%(95% CI,43.0-61.5)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Stereoelectroencephalography (SEEG) has become the criterion standard in case of inconclusive noninvasive presurgical epilepsy workup. However, up to 40% of patients are subsequently not offered surgery because the seizure-onset zone is less focal than expected or cannot be identified. OBJECTIVE: To predict focality of the seizure-onset zone in SEEG, the 5-point 5-SENSE score was developed and validated. DESIGN, SETTING, AND PARTICIPANTS: This was a monocentric cohort study for score development followed by multicenter validation with patient selection intervals between February 2002 to October 2018 and May 2002 to December 2019. The minimum follow-up period was 1 year. Patients with drug-resistant epilepsy undergoing SEEG at the Montreal Neurological Institute were analyzed to identify a focal seizure-onset zone. Selection criteria were 2 or more seizures in electroencephalography and availability of complete neuropsychological and neuroimaging data sets. For validation, patients from 9 epilepsy centers meeting these criteria were included. Analysis took place between May and July 2021. MAIN OUTCOMES AND MEASURES: Based on SEEG, patients were grouped as focal and nonfocal seizure-onset zone. Demographic, clinical, electroencephalography, neuroimaging, and neuropsychology data were analyzed, and a multiple logistic regression model for developing a score to predict SEEG focality was created and validated in an independent sample. RESULTS: A total of 128 patients (57 women [44.5%]; median [range] age, 31 [13-58] years) were analyzed for score development and 207 patients (97 women [46.9%]; median [range] age, 32 [16-70] years) were analyzed for validation. The score comprised the following 5 predictive variables: focal lesion on structural magnetic resonance imaging, absence of bilateral independent spikes in scalp electroencephalography, localizing neuropsychological deficit, strongly localizing semiology, and regional ictal scalp electroencephalography onset. The 5-SENSE score had an optimal mean (SD) probability cutoff for identifying a focal seizure-onset zone of 37.6 (3.5). Area under the curve, specificity, and sensitivity were 0.83, 76.3% (95% CI, 66.7-85.8), and 83.3% (95% CI, 72.30-94.1), respectively. Validation showed 76.0% (95% CI, 67.5-84.0) specificity and 52.3% (95% CI, 43.0-61.5) sensitivity. CONCLUSIONS AND RELEVANCE: High specificity in score development and validation confirms that the 5-SENSE score predicts patients where SEEG is unlikely to identify a focal seizure-onset zone. It is a simple and useful tool for assisting clinicians to reduce unnecessary invasive diagnostic burden on patients and overutilization of limited health care resources.
引用
- Astner-Rohracher A, Zimmermann G, Avigdor T, et al. Development and Validation of the 5-SENSE Score to Predict Focality of the Seizure-Onset Zone as Assessed by Stereoelectroencephalography. JAMA Neurol. 2022. PMID: 34870697. doi:10.1001/jamaneurol.2021.4405
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。